MRSAid™ & VGH Infection Control Project Featured on Canadian National News!

Last Friday, we announced an innovative partnership with Vancouver General Hospital (VGH), one of Canada`s largest hospitals. Today, we are very excited to have this partnership featured on Global News.

MRSAidTM is a non-antibiotic therapy designed to eliminate bacteria in the noses of patients during high infection risk times. Pathogenic bacteria such as Staphylococcus aureus and MRSA can significantly increase the risk of a patient developing serious infections after surgery. As part of our partnership with VGH, MRSAidTM will be used on patients undergoing cardiac, spinal, breast reconstruction, thoracic, neurological, and orthopaedic surgeries. We are very excited to be working with the leaders in infection control at VGH. For more information on MRSAidTM, please visit www.mrsaid.com. Also, connect with us on TwitterFacebook, we`ll be happy to respond to any of your comments and questions.

Related Posts Plugin for WordPress, Blogger...

Leave a Reply

Staypressed theme by Themocracy